ropidoxuridine (5-iodo-2-pyrimidinone-2′-deoxyribose)

ropidoxuridine (5-iodo-2-pyrimidinone-2′-deoxyribose)
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2016-05-19 00:00:00
Sponsor EMEK, Inc.;196 Channel View;Warwick, Rhode Island, 02889
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM